These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22448173)

  • 1. Prospect of induced pluripotent stem cell genetic repair to cure genetic diseases.
    Adiwinata Pawitan J
    Stem Cells Int; 2012; 2012():498197. PubMed ID: 22448173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality.
    Strässler ET; Aalto-Setälä K; Kiamehr M; Landmesser U; Kränkel N
    Front Cardiovasc Med; 2018; 5():4. PubMed ID: 29423397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
    Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
    Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of induced pluripotent stem cells in lysosomal storage diseases.
    Kido J; Nakamura K; Era T
    Mol Cell Neurosci; 2020 Oct; 108():103540. PubMed ID: 32828964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
    Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
    Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for immune regulation in iPS cell-based cardiac regenerative medicine.
    Murata K; Ikegawa M; Minatoya K; Masumoto H
    Inflamm Regen; 2020; 40():36. PubMed ID: 33005258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
    Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
    Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
    Adamiak M; Cheng G; Bobis-Wozowicz S; Zhao L; Kedracka-Krok S; Samanta A; Karnas E; Xuan YT; Skupien-Rabian B; Chen X; Jankowska U; Girgis M; Sekula M; Davani A; Lasota S; Vincent RJ; Sarna M; Newell KL; Wang OL; Dudley N; Madeja Z; Dawn B; Zuba-Surma EK
    Circ Res; 2018 Jan; 122(2):296-309. PubMed ID: 29118058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using induced pluripotent stem cell-derived conditional medium to attenuate the light-induced photodamaged retina of rats.
    Chang HM; Hung KH; Hsu CC; Lin TC; Chen SY
    J Chin Med Assoc; 2015 Mar; 78(3):169-76. PubMed ID: 25557467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
    Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
    Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective restoration of dystrophin expression in iPSC
    Jin Y; Shen Y; Su X; Weintraub NL; Tang Y
    Comput Struct Biotechnol J; 2020; 18():765-773. PubMed ID: 32280431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into disease modeling using induced pluripotent stem cells.
    Egashira T; Yuasa S; Fukuda K
    Biol Pharm Bull; 2013; 36(2):182-8. PubMed ID: 23370349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
    Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
    J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
    Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
    Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
    Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
    Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of induced pluripotent stem cells to hematologic disease.
    Kim PG; Daley GQ
    Cytotherapy; 2009; 11(8):980-9. PubMed ID: 19929461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.